A Risk-Benefit Assessment of Pharmacotherapy for Anxiety Disorders in Children and Adolescents

被引：0
作者：
Susan M. Hawkridge
Dan J. Stein
机构：
[1] University of Stellenbosch,Department of Psychiatry
来源：
Drug Safety | 1998年 / 19卷
关键词：
Adis International Limited; Fluoxetine; Anxiety Disorder; Imipramine; Social Phobia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Few pharmacotherapy trials have been undertaken in young people with anxiety disorders. Of those conducted, few are placebo-controlled or blinded, and often sample size is small, making interpretation of the data difficult.
引用
收藏
页码：283 / 297
页数：14
相关论文
共 219 条
[1]  
Myers J.K.(1984)Six month prevalence of psychiatric disorders in three communities Arch Gen Psychiatry 41 959-67
[2]  
Weissman M.M.(1992)Chronic course of anxiety disorders in children and adolescents J Am Acad Child Adolesc Psychiatry 31 595-9
[3]  
Tischler G.L.(1990)DSM III disorders in a large sample of adolescents J Am Acad Child Adolesc Psychiatry 29 611-9
[4]  
Keller M.B.(1995)Current knowledge of medications for the treatment of childhood anxiety disorders J Am Acad Child Adolesc Psychiatry 34 976-86
[5]  
Lavori P.W.(1995)Ethical issues in biological psychiatric research with children and adolescents J Am Acad Child Adolesc Psychiatry 34 929-39
[6]  
Wunder J.(1990)A community study of anxiety in children and adolescents Am J Psychiatry 147 313-8
[7]  
McGee R.(1987)Assessing psychiatric disorders in children Arch Gen Psychiatry 4 747-53
[8]  
Feehan M.(1997)The Virginia twin study of adolescent behavioral development Arch Gen Psychiatry 54 801-8
[9]  
Williams S.(1997)Anxious children in adulthood: a prospective study of adjustment J Am Acad Child Adolesc Psychiatry 36 645-52
[10]  
Allen A.T.(1994)Treating anxiety disorders in children: results of a randomized clinical trial J Consult Clin Psychol 62 100-10
12345678910